Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester manufacturers
- Linaprazan glurate
-
- $2.00 / 100kg
-
2025-10-13
- CAS:1228559-81-6
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
|
| | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester Basic information |
| Product Name: | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester | | Synonyms: | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester;Linaprazan glurate;fast onset,Linaprazan glurate,gastric acid,gastrointestinal inflammatory diseases,peptic ulcer diseases,Inhibitor,inhibit;5-[2-[[[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethyl-6-imidazo[1,2-a]pyridinyl]-oxomethyl]amino]ethoxy]-5-oxopentanoic acid;5-(2-(8-((2,6-Dimethylbenzyl)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamido)ethoxy)-5-oxopentanoic acid | | CAS: | 1228559-81-6 | | MF: | C26H32N4O5 | | MW: | 480.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1228559-81-6.mol | ![Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester Structure](CAS/20210111/GIF/1228559-81-6.gif) |
| | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester Chemical Properties |
| density | 1.25±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | pka | 4.60±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester Usage And Synthesis |
| Uses | Linaprazan glurate inhibits exogenously or endogenously stimulated gastric acid secretion. Linaprazan glurate exhibits several advantageous properties, such as fast onset, high in vivo potency and/or long duration of action. Linaprazan glurate is useful in the research of gastrointestinal inflammatory diseases and peptic ulcer diseases (extracted from patent WO2010063876A1)[1]. | | References | [1] Mikael Dahlstr?m, et al. Imidazopyridine derivatives which inhibit the secretion of gastric acid. Patent WO2010063876A1. |
| | Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester Preparation Products And Raw materials |
|